Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2017-11-15, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: BSPM/20171115/10-Q/1/000.htm SEC Original: biostar10q063017.htm
FORM 10-Q (Mark One) ☒ June 30, 2017 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former

---

---

Webplus: BSPM/20171115/10-Q/2_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

---

---

Webplus: BSPM/20171115/10-Q/3_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Xiaojuan Zhai, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading

---

---

Webplus: BSPM/20171115/10-Q/4_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1

---

---

Webplus: BSPM/20171115/10-Q/5_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Xiaojuan Zhai Xiaojuan Zhai Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2

---

Company Info:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2017-11-15, XBRL Interactive FinancialsCIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046